Plunkett Research Online: Biondvax Pharmaceuticals Ltd

BIONDVAX PHARMACEUTICALS LTD (BVXV:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

BiondVax Pharmaceuticals Ltd is engaged in the healthcare sector. Its main activity is the commercialization and manufacturing of flu vaccine. Its product is designed to provide multi-season and multi-strain protection against some human influenza virus strains, including both seasonal and pandemic .....



Biondvax Pharmaceuticals Ltd
Ticker: BVXV
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 972 89302529
Fax: 972 89302531
Address: Hadassah Ein Kerem Campus
Jerusalem BioPark, 2nd Floor
Jerusalem, Israel

Map
Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
Contacts Description

BiondVax Pharmaceuticals Ltd is engaged in the healthcare sector. Its main activity is the commercialization and manufacturing of flu vaccine. Its product is designed to provide multi-season and multi-strain protection against some human influenza virus strains, including both seasonal and pandemic .....See More See More

Auditor: Kost, Forer, Gabbay & Kasierer
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2019 2018 2017 2016 2015 2014
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Name Title Salary (ILS) Bonus (ILS)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: